Latest News and Press Releases

ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to...

LONDON and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...

                 SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual acuity and aspects of color vision by creating an...

ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...

Dublin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The "Fair-Market Value Compensation Rates for Ophthalmology KOLs - United States" report has been added to ResearchAndMarkets.com's offering. Thought...

CRANBURY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ophthalmology Times®, a trusted clinical publication specialized in eye care, is proud to celebrate five decades of excellence in advancing...

42% reduction in mean intraocular pressure (IOP) compared to baseline (p<0.0001)100% of patients were off all topical IOP-lowering medications at 24 months100% of treated patients achieved 20/30 or...

BVI has received FDA approval for its FineVision HP® trifocal intraocular lens (IOL), a major milestone in advanced cataract surgery for U.S. patients.

ZUG, Switzerland, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and...

PASADENA, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that 10 of its affiliated clinician-scientists have been...